
Last updated: about 2 months ago
AstraZeneca's 6-K Report: Datroway Approved for Advanced Lung Cancer Treatment
AstraZeneca PLC announces the approval of Datroway for advanced EGFR-mutated lung cancer, highlighting clinical trial success and strategic collaboration with Daiichi Sankyo.